EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Effect of Asymptomatic and Symptomatic COVID-19 on Acute Ischemic Stroke Revascularization Outcomes

Davide Strambo iD, João Pedro Marto iD, George Ntaios iD, Thanh N Nguyen iD, Patrik Michel iD, Global COVID-19 Stroke Registry

Stroke · 2024

DOI: 10.1161/strokeaha.123.043899 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Stroke, 2024. Verfasst von Davide Strambo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Stroke Center, Neurology Service, Department of Neurological Sciences, Lausanne University Hospital, University of Lausanne, Switzerland (D.S., P.M.). Hauptthemen laut MEDLINE: Stroke, Ischemic Stroke, Brain Ischemia, COVID-19. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The association of COVID-19 with higher bleeding risk and worse outcomes in acute ischemic stroke (AIS) undergoing revascularization may be related to the presence of infection symptoms. We aimed to assess the safety and outcomes of revascularization treatments in patients with AIS with asymptomatic COVID-19 (AS-COVID) or symptomatic COVID-19 (S-COVID). METHODS: We conducted an international multicenter retrospective cohort study of consecutive AIS tested for SARS-CoV-2, receiving intravenous thrombolysis and endovascular treatment between 2020 and 2021. We compared COVID-negative controls, AS-COVID, and S-COVID using multivariable regression. We assessed symptomatic intracranial hemorrhage (symptomatic intracerebral hemorrhage), mortality, and 3-month disability (modified Rankin Scale score). RESULTS: Among 15 124 patients from 105 centers (median age, 71 years; 49% men; 39% treated with intravenous thrombolysis only; and 61% with endovascular treatment±intravenous thrombolysis), 849 (5.6%) had COVID-19, of whom 395 (46%) were asymptomatic and 454 (54%) symptomatic. Compared with controls, both patients with AS-COVID and S-COVID had higher symptomatic intracerebral hemorrhage rates (COVID-controls, 5%; AS-COVID, 7.6%; S-COVID, 9.4%; adjusted odds ratio [aOR], 1.43 [95% CI, 1.03–1.99]; aOR, 1.63 [95% CI, 1.14–2.32], respectively). Only in patients with symptomatic infections, we observed a significant increase in mortality at 24 hours (COVID-controls, 1.3%; S-COVID, 4.8%; aOR, 2.97 [95% CI, 1.76–5.03]) and 3 months (COVID-controls, 19.5%; S-COVID, 40%; aOR, 2.64 [95% CI, 2.06–3.37]). Patients with COVID-19 had worse 3-month disability regardless of disease symptoms although disability was affected to a greater extent in symptomatic patients (aOR for worse modified Rankin Scale score shift: AS-COVID, 1.25 [95% CI, 1.03–1.51]; S-COVID, 2.10 [95% CI, 1.75–2.53]). S-COVID had lower successful recanalization (74.9% versus 85.6%; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StrokeIschemic StrokeBrain IschemiaCOVID-19Endovascular ProceduresMaleHumansAgedFemaleThrombolytic TherapyRetrospective StudiesTreatment OutcomeSARS-CoV-2Cerebral HemorrhageIntracranial HemorrhagesThrombectomy

Stichwörter der Autor:innen

SARS-CoV-2endothelial cellsischemic strokerenin-angiotensin systemthrombosis

Autor:innen und Institutionen

  • Stroke Center, Neurology Service, Department of Neurological Sciences, Lausanne University Hospital, University of Lausanne, Switzerland (D.S., P.M.).
  • Department of Neurology, Hospital de Egas Moniz, Centro Hospitalar Lisboa Ocidental, Portugal (J.P.M.).
  • Departement of Internal Medicine, Faculty of Medicine, University of Thessaly, Larissa, Greece (G.N.).
  • Departement of Neurology, Boston Medical Center, MA (T.N.N.).

ORCID-Profile: Davide Strambo, João Pedro Marto, George Ntaios, Thanh N Nguyen, Patrik Michel

Zitieren

APA

Strambo, D., Marto, J. P., Ntaios, G., Nguyen, T. N., Michel, P., & Global COVID-19 Stroke Registry (2024). Effect of Asymptomatic and Symptomatic COVID-19 on Acute Ischemic Stroke Revascularization Outcomes. Stroke. https://doi.org/10.1161/strokeaha.123.043899

Vancouver

Strambo D, Marto JP, Ntaios G, Nguyen TN, Michel P, Global COVID-19 Stroke Registry. Effect of Asymptomatic and Symptomatic COVID-19 on Acute Ischemic Stroke Revascularization Outcomes. Stroke. 2024. doi:10.1161/strokeaha.123.043899

BibTeX
@article{Strambo2024,
  author = {Strambo, Davide and Marto, João Pedro and Ntaios, George and Nguyen, Thanh N and Michel, Patrik and Global COVID-19 Stroke Registry, Global COVID-19 Stroke Registry},
  title = {Effect of Asymptomatic and Symptomatic COVID-19 on Acute Ischemic Stroke Revascularization Outcomes},
  journal = {Stroke},
  year = {2024},
  doi = {10.1161/strokeaha.123.043899}
}
Kostenlos starten →